Craniosynostosis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The patients who diagnosed as craniosynostosis at Tokyo Metropolitan Children's Medical Center or joint research institutes of this clinical study, and undergo first transcranial surgery between September 1, 2021 and August 31, 2026.
Exclusion criteria
Exclusion criteria: (1) Cases in which the patients or their substitutes indicates the intention of refusal to participate in this study. (2) Others that the person in charge of registration at each facility deems inappropriate as a research subject.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Descriptive statistics on the epidemiology of craniosynostosis | — |
Secondary
| Measure | Time frame |
|---|---|
| Perform exploratory multivariate analysis on possible factors for blood transfusion of 25 mL or more per body weight, complications within 1 month after surgery, reoperation within 6 months after surgery, Whitaker classification score, developmental evaluation score. | — |
Countries
Japan
Contacts
Tokyo Metropolitan Children's Medical Center Department of Plastic and Reconstructive Surgery